CTRI/2016/06/007042
Completed
Phase 4
asopharyngeal pneumococcal carriage and immunogenicity with reduced and alternate dose schedule of pneumococcal conjugate vaccine in infancy.
KEM Hospital Research Centre0 sites805 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- KEM Hospital Research Centre
- Enrollment
- 805
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Healthy infants as established by medical history and clinical examination
- •6\-8 weeks of age at the time of enrolment.
- •Written informed consent obtained from the parent(s) of infants
- •Parent who intends to remain in the area with the child during the study period.
Exclusion Criteria
- •Acute disease at the time of enrolment (temporary exclusion)
- •Concurrent participation in another clinical trial during study period.
- •Presence of significant malnutrition (weight\-for\-height z\-score \<\-3SD median)
- •Presence of significant systemic disorder as determined by medical history and/or physical examination
- •Prior receipt of pneumococcal vaccine
- •Known sensitivity or allergy to any components of the study vaccine
- •Major congenital or genetic defect
- •Has received any immunoglobulin therapy and/or blood products since birth or planned administration during the study period.
- •History of chronic administration (defined as more than 14 days) of immune\-suppressants including corticosteroids.
- •Any medical condition in the subject, which, in the judgment of the investigator, would interfere with protocol adherence or participantâ??s parentsâ?? ability to give informed consent.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
asopharyngeal pneumococcal colonization data in infants at the age of 12, 18 and 24 months - Pneumococcal carriage in infantsEUCTR2008-000083-17-NLederlands Vaccin Instituut
Completed
Phase 3
Serological Response to Antipneumococcal Vaccination and Impact on Streptococcus Pneumoniae Nasal Carriage in HIV AdultsHIV InfectionPneumococcal InfectionsNCT02123433University of Siena50
Not yet recruiting
Phase 2
Pneumococcal Nasopharyngeal Carriage in Thai ChildreHealthy Thai children aged 1 month to not more than 5 yearsnasopharyngeal carriageseroprevalencepneumococcal conjugate vaccinestreptococcus pneumoniaantimicrobial susceptibilityTCTR20240624005Pediatric Infectious Disease Society of Thailand (PIDST)1,000
Completed
Not Applicable
Streptococcus pneumoniae: Nasopharyngeal and Oropharyngeal Carriage in Nursing Home Residentsnaso-/oropharyngeal pneumococcal carriagenaso-/oropharyngeal bacterial carriageDRKS00004833niversitätsklinikum Jena542
Completed
Phase 3
Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850AInfections, StreptococcalStreptococcus PneumoniaeNCT00839254GlaxoSmithKline6,181